These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 21448295)

  • 1. Developments in administration of growth hormone treatment: focus on Norditropin® Flexpro®.
    Yuen KC; Amin R
    Patient Prefer Adherence; 2011 Mar; 5():117-24. PubMed ID: 21448295
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ease of use and acceptability of a new pen device for the administration of growth hormone therapy in pediatric patients: an open-label, uncontrolled usability test.
    Fuchs GS; Mikkelsen S; Knudsen TK; Kappelgaard AM
    Clin Ther; 2009 Dec; 31(12):2906-14. PubMed ID: 20110030
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patient preference for a new growth hormone injection device: results of an open-label study in Japanese pediatric patients.
    Kappelgaard AM; Mikkelsen S; Knudsen TK; Fuchs GS
    J Pediatr Endocrinol Metab; 2011; 24(7-8):489-96. PubMed ID: 21932587
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Product wastage from modern human growth hormone administration devices: a laboratory and computer simulation analysis.
    Pollock RF; Qian Y; Wisniewski T; Seitz L; Kappelgaard AM
    Med Devices (Auckl); 2013; 6():107-14. PubMed ID: 23946672
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of user-friendliness of the Norditropin FlexPro for pediatric patients treated with recombinant human growth hormone: results of an open-label user survey.
    Adachi M
    J Pediatr Endocrinol Metab; 2013; 26(11-12):1105-10. PubMed ID: 23843576
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of injection dose force, accuracy and precision among three growth hormone injection devices.
    Kappelgaard AM; Hansen NÅ
    Expert Rev Med Devices; 2013 May; 10(3):321-7. PubMed ID: 23560872
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Children and adolescent acceptability of a new device system to administer human growth hormone--a pilot study.
    Kappelgaard AM; Mikkelsen S; Bagger C; Fuchs GS
    J Pediatr Endocrinol Metab; 2012; 25(3-4):285-94. PubMed ID: 22768658
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Growth hormone therapy with norditropin ( somatropin ) in growth hormone deficiency.
    Pawlikowska-Haddal A
    Expert Opin Biol Ther; 2013 Jun; 13(6):927-32. PubMed ID: 23662811
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Norditropin SimpleXx: a liquid human growth hormone formulation, a pen system and an auto-insertion device.
    Müller J; Skakkebaek NE; Jacobsen BB; Keller E; Heinrich U; Hartmann K; Hokken-Koelega AC; Delemarre van de Waal HA
    Horm Res; 1999; 51 Suppl 3():109-12. PubMed ID: 10592453
    [TBL] [Abstract][Full Text] [Related]  

  • 10. User assessment of Norditropin NordiFlex(®), a new prefilled growth hormone pen: a Phase IV multicenter prospective study.
    Tauber M; Jaquet D; Jesuran-Perelroizen M; Petrus M; Bertrand AM; Coutant R;
    Patient Prefer Adherence; 2013; 7():455-62. PubMed ID: 23737664
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of intuitiveness, ease of use and preference among three prefilled, disposable growth hormone injection pens.
    Rohrer TR; Winter F; Qvist M; Kappelgaard AM
    Expert Opin Drug Deliv; 2013 Dec; 10(12):1603-12. PubMed ID: 24073645
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Attenuation of Human Growth Hormone-Induced Rash With Graded Dose Challenge.
    Mann J; Caruana D; Luo E; Gottesman E; Agrawal N; Lozeau D; Hessel J; Neumann M; Khanijo S; Hasan Z; Rizvi K; Gunther R; Donovan D; Chan D; Lee-Wong M; Szema AM
    Cureus; 2022 Aug; 14(8):e27920. PubMed ID: 36110455
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A new pen device for injection of recombinant human growth hormone: a convenience, functionality and usability evaluation study.
    Sauer M; Abbotts C
    Patient Prefer Adherence; 2018; 12():27-34. PubMed ID: 29343946
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Psychological responses to the needle-free Medi-Jector or the multidose Disetronic injection pen in human growth hormone therapy.
    Verrips GH; Hirasing RA; Fekkes M; Vogels T; Verloove-Vanhorick SP; Delemarre-Van de Waal HA
    Acta Paediatr; 1998 Feb; 87(2):154-8. PubMed ID: 9512200
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insulin pen needles: effects of extra-thin wall needle technology on preference, confidence, and other patient ratings.
    Aronson R; Gibney MA; Oza K; Bérubé J; Kassler-Taub K; Hirsch L
    Clin Ther; 2013 Jul; 35(7):923-933.e4. PubMed ID: 23790553
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ease of use and preference for a new disposable self-injection pen compared with a reusable pen for administering recombinant human growth hormone: A multicenter, 2-month, single-arm, open-label clinical trial in patient-caregiver dyads.
    Hey-Hadavi J; Pleil A; Deeb LC; Fuqua JS; Silverman LA; Reiner B; Newfield R; Rajicic N; Wajnrajch MP; Cara JF
    Clin Ther; 2010 Nov; 32(12):2036-47. PubMed ID: 21118739
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost minimization analysis of different growth hormone pen devices based on time-and-motion simulations.
    Nickman NA; Haak SW; Kim J
    BMC Nurs; 2010 Apr; 9():6. PubMed ID: 20377905
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Growth hormone therapy with a new delivery system.
    Jørgensen JT; Susgaard S
    Indian J Pediatr; 1991; 58 Suppl 1():43-50. PubMed ID: 1824374
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acceptability of Liquid Human Growth Hormone (hGH) [Norditropin Simple Xx®] in Adults and Children with GH Deficiency and Children with Chronic Renal Disease.
    Drent ML; Jakobsdottir S; van Wijk JAE; Oostdijk W; Wit JM
    Clin Drug Investig; 2002 Sep; 22(9):633-638. PubMed ID: 29492857
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Results from an international multicenter trial evaluating the ease-of-use of and preference for a newly developed disposable injection pen for the treatment of growth hormone deficiency in treatment-naïve children and adults.
    Pleil AM; Darendeliler F; Dörr HG; Hutchinson K; Wollmann HA
    Med Devices (Auckl); 2014; 7():61-71. PubMed ID: 24748824
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.